Giant has updated two of its helmets, both with wind-tunnel developed aero features. While the Pursuit is an aero road helmet ...

Find out how MIPS Value Pathways simplify reporting, lessen the administration burden, and coordinate quality metrics with ...

Call to do better with chips and put AI everywhere is more than rhetoric because China’s scientists are sprinting ahead China ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

A China-linked advanced persistent threat actor tracked as UAT-9244 has been targeting telecommunication service providers in South America since 2024, compromising Windows, Linux, and network-edge ...

In Vancouver, seasons overlap and the weather keeps you guessing—we pedal through the cold, and the rain jacket never leaves the car. With March here, patios are opening, group chats are shifting from ...

New rule elevates medical-dental integration and highlights the role of primary care in oral health outcomes Smiles for ...

The weather is warming, and cyclists have an eye on the bike paths. Find your dream ride at the Gatineau-Ottawa Bicycle Show!

Chiplet Summit, the industry's largest chiplet event, today announced that MIPS, a GlobalFoundries company, will participate in Chiplet Summit 2026, February 17-19 at the Santa Clara Convention Center ...

ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash ...

Mips AB (FRA:7M1) reports impressive organic growth and strategic acquisitions, despite facing legal and market headwinds.

The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...